US Stock MarketDetailed Quotes

CLLS Cellectis

Watchlist
  • 1.280
  • +0.060+4.92%
Trading Mar 11 10:09 ET
128.12MMarket Cap-1.09P/E (TTM)

About Cellectis Company

Cellectis SA operates as a clinical stage biotechnological company, which engages in gene-editing platform to develop cell and gene therapies. The company was founded by David J. Sourdive and André Choulika on February 20, 1999 and is headquartered in Paris, France.

Company Profile

SymbolCLLS
Company NameCellectis
Listing DateMar 25, 2015
Issue Price36.83
Founded1999
CEODr. Andre Choulika
MarketNASDAQ
Employees221
Securities TypeDR
ADS Ratio1.0 : 1.0
Fiscal Year Ends12-31
Address8, rue de la Croix Jarry
CityParis
ProvinceIle-de-France
CountryFrance
Zip Code75013
Phone33-1-81-69-16-00
Websitehttp://www.cellectis.com

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Andre Choulika
  • Director and Chief Executive Officer
  • 1.13M
  • Dr. David Sourdive
  • Director, Deputy Chief Executive Officer and Executive Vice President, CMC and Manufacturing
  • 657.84K
  • Dr. Mark Frattini, M.D.,PhD
  • Chief Medical Officer
  • --
  • Philippe Duchateau, PhD
  • Chief Scientific Officer
  • --
  • Bing Wang, PhD
  • Chief Financial Officer
  • --
  • Kyung Nam-Wortman
  • Executive Vice President and Chief Human Resources Officer
  • --
  • Arthur Stril
  • Chief Business Officer
  • --
  • Stephan Reynier
  • Chief Regulatory and Pharmaceutical Compliance Officer
  • --
  • Dr. Steven Doares, PhD
  • Senior Vice President, US Manufacturing
  • --
  • Dr. Jean-Pierre Garnier, PhD
  • Chairman of the Board
  • 203.80K
  • Laurent Arthaud
  • Director
  • --
  • Cecile Chartier
  • Independent Director
  • 47.77K
  • Rainer J. Boehm, M.B.A.
  • Independent Director
  • 99.60K
  • Axel-Sven Malkomes
  • Independent Director
  • 102.75K
  • Pierre Tristan Michel Bastid
  • Independent Director
  • 97.34K
  • Dr. Donald A. Bergstrom, M.D.,PhD
  • Independent Director
  • 102.75K
  • Marie-Bleuenn Terrier
  • General Counsel
  • --

Trending Stocks

U.S Tech Companies U.S Tech Companies

U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.

No. Symbol Price
Alibaba
BABA
137.060
Broadcom
AVGO
188.080
Netflix
NFLX
882.910
4
Microsoft
MSFT
384.000
5
Salesforce
CRM
275.330
Log In for the Full List
Unlock Now
Investment Course
Top 5 Industries for Stock Trading under Trump's Second Term
Stocks & Industries to Watch Under Trump's Second Presidency
With mooomoo, find out which stocks and industries may benefit from Trump's second presidency, based on his first administration's track record.
Reassessing Chinese Assets
Following the introduction of China's groundbreaking DeepSeek technology, Wall Street giants have revised their investment outlooks for the Chinese market.
Discussing
Tesla's earnings caused fluctuations, what's your market outlook？
Tesla's Q4 2024 revenue was $25.71 billion, up 2% year-on-year but below expectations. Can Tesla's stock price keep rising in 2025 with Trum Show More
TSLA earnings preview: Grab rewards by guessing the opening price!